SAGE Stock Set to Sell-Off After Seizure Drug Failure

SAGE shares are set to lose one-quarter of their value

Sep 12, 2017 at 9:21 AM
facebook X logo linkedin

U.S. stocks look poised to extend Monday's huge rally. Among specific stocks in focus are biotech stocks Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and SAGE Therapeutics Inc (NASDAQ:SAGE), as well as e-commerce giant, Inc. (NASDAQ:AMZN). Here's a quick look at what's boosting shares of TEVA, SAGE, and AMZN. 

TEVA Stock Looks for More Upside After Paragard Sale

Teva Pharmaceutical is in focus again, with the company announcing it's selling its Paragard brand for $1.1 billion. The shares are now ready to open 6.8% higher, after closing yesterday at $18.50 -- their highest close in over a month. Still, TEVA remains 63.2% lower during the past 12 months, and Jefferies this morning cut its price target to $21 from $26. As such, the equity is trying to pull itself out of oversold territory, with its 14-day Relative Strength Index (RSI) last seen at 19. 

Drug Trial Results Crush SAGE 

SAGE Therapeutics stock is getting torched ahead of the open, falling 24.3%, after the company's seizure drug failed in a late-stage trial. This is a stunning setback for an outperforming equity, with the shares adding 127% year-over-year to trade at $88.52, while hitting a record high of $90.80 just last week. 

A round of bearish analyst attention could follow today's news. For example, nine of 11 brokerage firms say to buy SAGE stock. Watch out for downgrades to come through in the near term and pressure the security even lower. 

Whole Foods Foot Traffic Increases After Amazon Deal

Amazon stock is edging higher this morning, thanks to reports that customer traffic at Whole Foods has increased 25% since it was bought out by the e-commerce company. AMZN shares settled yesterday at $977.96, up 30.4% year-to-date. However, the security's formerly supportive 50-day moving average has served as a technical ceiling since early August. Either way, it's a good time to target near-term options, based on Amazon's Schaeffer's Volatility Index (SVI). This reading of 17% sits just 13 percentage points from a 12-month high, meaning volatility expectations are relatively muted at the moment for short-term contracts. 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI